Search research articles
Contact Us
Filters
Showing results (551-560 of 646) with videos related to
Page
of 65
Sort By:
Respiratory Research
|
August 23, 2017
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
Colin Reisner, Leonardo M Fabbri, Edward M Kerwin, et al.
Respiratory Medicine
|
October 31, 2024
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
January 19, 2006
[Guidelines for diagnosis and therapy of patients with asthma 2005. The most important aspects for adults]
Gerhard Schultze-Werninghaus, Peter Kardos, Dietrich Berdel, et al.
The European Respiratory Journal
|
April 13, 2012
Extracellular matrix composition in COPD
Raquel Annoni, Tatiana Lanças, Ryan Yukimatsu Tanigawa, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials
Fernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
Journal of Asthma and Allergy
|
March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Jonathan Corren, David J Jackson, Thomas B Casale, et al.
Cancer Research
|
May 20, 2016
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
Sebastian Marwitz, Sofia Depner, Dmytro Dvornikov, et al.
The European Respiratory Journal
|
December 14, 2022
Development of a tool to detect small airways dysfunction in asthma clinical practice
Janwillem Kocks, Thys van der Molen, Jaco Voorham, et al.
Advances in Therapy
|
May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
William W Busse, Jorge F Maspero, Klaus F Rabe, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 8, 2022
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
Peter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
Page
of 65
Search research articles
Search
Showing results (551-560 of 646) with videos related to
Sort By:
Page
of 65
Respiratory Research
|
August 23, 2017
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
Colin Reisner, Leonardo M Fabbri, Edward M Kerwin, et al.
Respiratory Medicine
|
October 31, 2024
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
January 19, 2006
[Guidelines for diagnosis and therapy of patients with asthma 2005. The most important aspects for adults]
Gerhard Schultze-Werninghaus, Peter Kardos, Dietrich Berdel, et al.
The European Respiratory Journal
|
April 13, 2012
Extracellular matrix composition in COPD
Raquel Annoni, Tatiana Lanças, Ryan Yukimatsu Tanigawa, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials
Fernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
Journal of Asthma and Allergy
|
March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Jonathan Corren, David J Jackson, Thomas B Casale, et al.
Cancer Research
|
May 20, 2016
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
Sebastian Marwitz, Sofia Depner, Dmytro Dvornikov, et al.
The European Respiratory Journal
|
December 14, 2022
Development of a tool to detect small airways dysfunction in asthma clinical practice
Janwillem Kocks, Thys van der Molen, Jaco Voorham, et al.
Advances in Therapy
|
May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
William W Busse, Jorge F Maspero, Klaus F Rabe, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 8, 2022
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
Peter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
Page
of 65